The T.I.G.C. has developed a series of Clinical Guides developed to help the clinician keep up-to-date with the management of thromboembolic disease. These Clinical Guides are developed by TIGC members, based on a review of the medical literature, when possible guidelines are evidence based, represent a consensus view of the TIGC membership and are adapted to Canadian medical practice.

Disclaimer: This site is designed as a resource for the health care professional. Please note that these recommendations must be viewed as general clinical guides based on current knowledge. Their application must be adapted to individual patients. The Thrombosis Interest Group assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.

	Category Clinical Guides Adobe pdf Antiplatelet Therapy Antiplatelet Therapy Post MI pdf pdf Antiphospholipids Antiphospholipid Syndrome pdf Cancer and Thrombosis Cancer & Thrombosis pdf Central Lines Cancer & Thrombosis pdf Diagnosis Cancer & Thrombosis Suspected PE - Under review pdf pdf DVT Cancer & Thrombosis VTE Prophylaxis in Major Orthopedic Surgery Initial Treatment of Venous Thromboembolism - Under review Inferior Vena Cava Filters - Under review Post-Thrombotic Syndrome Prevention of Deep Vein Thrombosis in Medical Patients Overview of Perioperative Management of Warfarin Therapy pdf pdf pdf pdf pdf pdf pdf f Duration of Anticoagulation Duration of Oral Anticoagulant Therapy for VTE pdf Heparin Unfractionated Heparin - Under Review Heparin in Children Heparin Induced Thrombocytopenia - (HIT) - Under Review Establishing a Therapeutic Range for Heparin - Under review pdf pdf pdf pdf Inferior Vena Cava Filters Cancer & Thrombosis Inferior Vena Cava Filters Initial Treatment of Venous Thromboembolism - Under review   pdf pdf pdf INR Oral Vitamin K Antagonists - Under review Warfarin in Children pdf pdf Low Molecular Weight Heparin (LMWH) Cancer & Thrombosis Initial Treatment of Venous Thromboembolism - Under Review Thrombosis in Pregnancy - Under review pdf pdf pdf MI Antiplatelet Therapy Post MI Thrombolytic Therapy in Myocardial Infarction - Under review Overview of Perioperative Management of Warfarin Therapy pdf pdf pdf pdf Pediatrics Heparin in Children Thrombolytic Therapy in Children Warfarin in Children pdf pdf pdf Pregnancy Thrombosis in Pregnancy - Under review pdf Prevention Antiplatelet Therapy VTE Prophylaxis in Major Orthopedic Surgery Prevention of Ischemic Stroke  Stroke Prevention in Atrial Fibrillation Overview of Perioperative Management of Warfarin Therapy pdf pdf pdf pdf pdf Pulmonary Embolism Suspected PE - Under review Initial Treatment of Venous Thromboembolism - Under Review Inferior Vena Cava Filters Overview of Perioperative Management of Warfarin Therapy pdf f pdf pdf pdf Stroke Antiplatelet Therapy Overview of Perioperative Management of Warfarin Therapy Prevention of Ischemic Stroke Stroke Prevention in Atrial Fibrillation Thrombolysis for Acute Ischemic Stroke pdf pdf pdf pdf Thrombophilia/ Hypercoagulable States Heparin Induced Thrombocytopenia - (HIT) - Under Review Investigation of Hypercoagulable States - Under Review pdf pdf Thrombolytic Therapy Thrombolytic Therapy in Peripheral Arterial Disease Thrombolytic Therapy in Children Thrombolytic Therapy in Myocardial Infarction Thrombolysis for Acute Ischemic Stroke Prevention of Deep Vein Thrombosis in Medical Patients pdf pdf pdf pdf VTE Suspected PE - Under review Thrombosis in Pregnancy - Under review Initial Treatment of Venous Thromboembolism - Under review Inferior Vena Cava Filters Post-Thrombotic Syndrome Overview of Perioperative Management of Warfarin Therapy pdf pdf f pdf pdf pdf pdf Warfarin Duration of Oral Anticoagulant Therapy for VTE Oral Vitamin K Antagonists (Warfarin) Patient Information Post MI Warfarin in Children Managing warfarin associated coagulopathy Using Point of Care INR Monitoring Overview of Perioperative Management of Warfarin Therapy pdf pdf pdf pdf pdf pdf pdf pdf

TIGC Publications

1. INR reporting in Canadian medical laboratories: a Thrombosis Interest Group of Canada survery. Am J Hematol 1995;48:237-239.
2. INR reporting in Canadian medical laboratories: an update. Am J Clin Pathol 1998:589-594.
3. A cross-Canada survey of prothrombin time testing. Does the establishment of local ISI values improve the accuracy of International Normalized Ratio reporting? Am J Clin Pathol 1998;110:683-690.
4. A survey of APTT reporting in Canadian medical laboratories: the need for increased standardization. Am J Clin Pathol in press.